Peripheral Liquid Embolic Agents Market Forecast (2024-2031)
The peripheral liquid embolic agents market size is projected to reach US$ 81.41 million by 2031 from US$ 40.42 million in 2023. The market is expected to register a CAGR of 9.1% during 2023–2031. The growing focus and developments in temperature-induced phase change systems and pH-triggered embolic agents are likely to bring new trends in the peripheral liquid embolic agents market
Peripheral Liquid Embolic Agents Market Analysis
Liquid embolic agents are used primarily in minimally invasive procedures, such as embolization, for treating aneurysms, arteriovenous malformations, tumors, and other conditions. These agents provide a less invasive alternative to traditional surgical methods and allow physicians greater control and precision in closing blood vessels while minimizing patient trauma and recovery times. Technological innovations are expected to improve product performance and promote broader adoption in various downstream applications. Furthermore, the peripheral liquid embolic agents market is growing because of the increasing adoption and acceptance by patients and healthcare professionals owing to the increasing awareness of the benefits provided by liquid embolic agents in the treatment of peripheral vascular diseases.
Peripheral Liquid Embolic Agents Market Overview
Liquid embolic agents are used to treat peripheral vascular diseases such as varicocele and peripheral artery embolization. The market for these agents is driven by the increasing preference of patients and healthcare professionals for minimally invasive procedures. The introduction of the latest medical technology, such as liquid embolic agents, supported by rising healthcare expenditure globally and improving healthcare infrastructure in emerging markets, is driving the peripheral liquid embolic agents market expansion. In addition, favorable reimbursement practices for minimally invasive procedures using liquid embolic agents in many countries are promoting their acceptance and driving market expansion.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Peripheral Liquid Embolic Agents Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Peripheral Liquid Embolic Agents Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Peripheral Liquid Embolic Agents Market Drivers and Opportunities
Rising Incidence of Peripheral Vascular Diseases
Peripheral vascular disease (PVD) consists of peripheral arterial disease (PAD) and venous disease. The growing prevalence of PVD can be attributed to the proliferating aging population that increases the visibility of its various diagnostic and treatment modalities. According to the article “Income-Related Peripheral Artery Disease Treatment,” published in the National Library of Medicine, more than 200 million people across the world suffer from PAD, and ~10% of people aged 50 years and above have been affected by the disease in Western Europe and North America. The prevalence of PVD ranges from 3% in patients aged >55 years and 11% in patients aged >65 years to 20% in patients aged >75. According to a study published in the National Library of Medicine titled "Secular Trends in the Epidemiological Patterns of Peripheral Artery Disease and Risk Factors in China," the number of people suffering from peripheral arterial disease in China increased by 40% between 2000 and 2020. In 2020, ~41 million adults in China were affected by PAD. In 2020, epidemiological research in China also found that the prevalence of PAD in the general population aged 35 years and above was 6%, and the prevalence of PAD in elderly over 60 years of age was 15% in China. It is estimated that there are more than 30 million patients suffering from peripheral artery disease in the country.
The rising prevalence of PVD is attributed to the increasing risk factors associated with diabetes, smoking, obesity, and age. With unhealthy lifestyle changes and the availability of medications not enough to treat PVD symptoms, minimally invasive procedures using peripheral stents are often the standard treatment. Cerebrovascular/carotid disease, peripheral arterial disease, and abdominal aortic aneurysms are among the most common peripheral vasculopathies reported by primary care physicians. All require aggressive medical treatment to prevent potentially serious complications and require vascular surgeons for evaluation. Liquid embolic agents are usually injected and introduced into the vascular malformation sites using a catheter guided by X-ray imaging (i.e., angiography). After infusion of the liquid embolic agents, it changes into a solid implant in situ, based on different mechanisms, including precipitation, polymerization, and cross-linking, through ionic or thermal processes. Liquid embolic agents do not rely on the patient's coagulation system for complete occlusion and may be effective even in patients suffering from severe coagulopathy. If a catheter cannot reach a bleeding site, liquid agents can provide embolization distal to the catheter tip. Long-term treatment strategies, better outcomes, and regulations to reduce cardiovascular mortality are recommended by all major regions, comprising the European Society of Cardiology (ESC), the European Society for Vascular Surgery (ESVS), the American Heart Association (AHA), and American College of Cardiology (ACC). Therefore, the growing prevalence of PVD drives the peripheral liquid embolic agents market growth.
Growing Strategic Initiatives by Market Players
Market players are constantly focusing on maintaining their leadership position in the market by continuously working toward strategic initiatives, introducing new products, and improving the existing products to broaden the usage of peripheral liquid embolic agents.
- In November 2023, Fluidx Medical Technology announced the development of its ultra-peripheral embolism platform for bleeding, tumor treatment, and other proximal embolization applications. The press release states that the ultra platform is designed to make catheter-based therapeutic embolization procedures safer, better, and faster.
- In October 2023, Sirtex Medical announced the commercial availability of the LAVA - Liquid Embolic System, a liquid embolic agent approved for treating peripheral vascular bleeding. LAVA offers volume and viscosity options that optimize flexibility in treating patients with controlled target vessel occlusion. The product's 2 mL and 6 mL options are optimized for the peripheral vasculature, and its viscosity options enable distal embolization of small vessels that may not be accessible via other emboli.
- In May 2023, Grand Pharmaceutical Group Ltd. acquired an 87.5% stake in Blackswan Vascular Inc., a company developing liquid embolism for peripheral vascular applications. The company continues to expand its presence in tumor intervention.
Thus, new product launches based on advancements and strategic initiatives are likely to provide new opportunities for the peripheral liquid embolic agents market in the coming years.
Peripheral Liquid Embolic Agents Market Report Segmentation Analysis
Key segments that contributed to the derivation of the peripheral liquid embolic agents market analysis are type and application.
- By type, the peripheral liquid embolic agents market is bifurcated into polymerizing liquid embolic agents and precipitating liquid embolic agents. In 2023, the precipitating liquid embolic agents segment held a larger market share and is anticipated to register a higher CAGR during 2023–2031.
- In terms of application, the market is segmented into endoleak type II, malformations, bleedings and trauma, varicose vein, tumors, and visceral aneurysm. In 2023, the endoleak type II segment held the largest share of the market. However, the bleedings and trauma segment is estimated to register the highest CAGR from 2023 to 2031.
Peripheral Liquid Embolic Agents Market Share Analysis by Geography
The geographic scope of the peripheral liquid embolic agents market report is mainly divided into five regions: North America, Asia Pacific, Europe, the Middle East & Africa, and South & Central America.
North America holds the largest share of the peripheral liquid embolic agents market. The regional market growth is propelled by the increasing incidence of vascular diseases, growing strategic initiatives by the market players, supportive government plans, and the development of innovative liquid embolic products. Canada held the largest share of the peripheral liquid embolic agents market in North America in 2023. The market is expected to grow owing to the availability of advanced healthcare infrastructure and rising incidence of target conditions. However, Asia Pacific is expected to register the highest CAGR during 2023–2031. The Asia Pacific market growth is driven by various factors such as the rising prevalence of peripheral artery diseases (PAD), increasing demand for minimally invasive procedures, growing number of hospitals and ambulatory surgery centers, market players are focusing on developing countries for growth opportunities, and developing healthcare infrastructure in Asia Pacific. In the region, China held the largest market share in 2023 as the market players in China are engaged in strategic activities to expand their footprint in the market. In May 2021, Grand Pharmaceutical and Healthcare Holdings Limited acquired Shenming Medical Technology Co., Ltd. The company obtained all rights of an innovative thermosensitive embolic agent that is used for liver cancer treatment, further expanding the tumor intervention treatment product pipeline.
Peripheral Liquid Embolic Agents Market Report Scope
Peripheral Liquid Embolic Agents Market News and Recent Developments
The peripheral liquid embolic agents market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the peripheral liquid embolic agents market are listed below:
- CERENOVUS Inc., launched TRUFILL n-BCA Liquid Embolic System Procedural Set. The latest addition to the CERENOVUS hemorrhagic stroke portfolio offers TRUFILL n-BCA Liquid Embolic System as a new procedural set that includes two configurations and the accessories needed to prep and deliver n-BCA Liquid Embolic System in one sterilized set, creating streamlined procedure preparation. (Source: Johnson & Johnson, Press Release, March 2024)
- Sirtex Medical (“Sirtex”), launched a first-of-its-kind product to treat peripheral vascular hemorrhage. LAVA provides volume and viscosity options that optimize the flexibility to treat patients affected by controlled target vessel occlusion. The product’s ability to maximize the packing density within the target vessel is incredibly important, as it allows to minimize the likelihood of a future recurrence or restoration of vessel patency. (Source: Sirtex Medical, Press Release, October 2023)
- Balt opened a second office in France. The Paris office would house members of the sales, marketing, clinical affairs, finance, IT, legal, HR, and communication teams. (Source: Balt, Press Release, June 2022)
Peripheral Liquid Embolic Agents Market Report Coverage and Deliverables
The “Peripheral Liquid Embolic Agents Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering the following areas:
- Peripheral liquid embolic agents market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Peripheral liquid embolic agents market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Peripheral liquid embolic agents market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the peripheral liquid embolic agents market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The market is estimated to reach US$ 81.41 million by 2031.
North America dominated the market in 2023.
The rising incidence of peripheral vascular diseases and upsurging demand for minimally invasive procedures are among the factors driving the market.
Medtronic, Gem Srl, MicroVention Inc, Johnson and Johnson, and Balt are among the leading players operating in the market.
The growing focus and developments in temperature-induced phase change systems and pH-triggered embolic agents are likely to bring new trends in the market.
The market is expected to register a CAGR of 9.1% during 2023–2031.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Peripheral Liquid Embolic Agents Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Regional Pricing Analysis, 2023
5. Peripheral Liquid Embolic Agents Market – Key Market Dynamics
5.1 Peripheral Liquid Embolic Agents Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Incidence of Peripheral Vascular Diseases
5.2.2 Increasing Demand for Minimally Invasive Procedures
5.3 Market Restraints
5.3.1 High Cost of Embolization Agents
5.4 Market Opportunities
5.4.1 Growing Strategic Initiatives by Market Players
5.5 Future Trends
5.5.1 Developments in Temperature-Induced Phase Change Systems and pH-Triggered Embolic Agents
5.6 Impact analysis
6. Peripheral Liquid Embolic Agents Market – Global Market Analysis
6.1 Peripheral Liquid Embolic Agents Market Revenue (US$ Thousand), 2021–2031
6.2 Peripheral Liquid Embolic Agents Market Analysis
6.3 Market Positioning Analysis, 2023
7. Peripheral Liquid Embolic Agents Market Analysis – by Type
7.1 Polymerizing Liquid Embolic Agent
7.1.1 Overview
7.1.2 Polymerizing Liquid Embolic Agent: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
7.2 Precipitating Liquid Embolic Agent
7.2.1 Overview
7.2.2 Precipitating Liquid Embolic Agent: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
8. Peripheral Liquid Embolic Agents Market Analysis – by Application
8.1 Endoleak Type II
8.1.1 Overview
8.1.2 Endoleak Type II: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
8.2 Malformations
8.2.1 Overview
8.2.2 Malformations: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
8.3 Bleedings and Trauma
8.3.1 Overview
8.3.2 Bleedings and Trauma: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
8.4 Varicose Vein
8.4.1 Overview
8.4.2 Varicose Vein: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
8.5 Tumours
8.5.1 Overview
8.5.2 Tumours: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
8.6 Visceral Aneurysm
8.6.1 Overview
8.6.2 Visceral Aneurysm: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9. Peripheral Liquid Embolic Agents Market – Geographical Analysis
9.1 North America
9.1.1 North America Peripheral Liquid Embolic Agents Market Overview
9.1.2 North America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.1.2.1 North America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Type
9.1.2.2 North America: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Type
9.1.2.2.1 North America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Polymerizing Liquid Embolic Agent
9.1.2.2.2 North America: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Polymerizing Liquid Embolic Agent
9.1.2.2.3 North America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Precipitating Liquid Embolic Agent
9.1.2.2.4 North America: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Precipitating Liquid Embolic Agent
9.1.2.3 North America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Application
9.1.3 North America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Country
9.1.3.1 Canada: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.1.3.1.1 Canada: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.1.3.1.1.1 Canada: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.1.3.1.1.2 Canada: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.1.3.1.2 Canada: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.1.3.2 Mexico: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.1.3.2.1 Mexico: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.1.3.2.1.1 Mexico: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.1.3.2.1.2 Mexico: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.1.3.2.2 Mexico: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.2 Europe
9.2.1 Europe Peripheral Liquid Embolic Agents Market Overview
9.2.2 Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2.2.1 Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Type
9.2.2.2 Europe: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Type
9.2.2.2.1 Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Polymerizing Liquid Embolic Agent
9.2.2.2.2 Europe: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Polymerizing Liquid Embolic Agent
9.2.2.2.3 Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Precipitating Liquid Embolic Agent
9.2.2.2.4 Europe: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Precipitating Liquid Embolic Agent
9.2.2.3 Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Application
9.2.3 Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Country
9.2.3.1 Germany: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2.3.1.1 Germany: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.2.3.1.1.1 Germany: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.2.3.1.1.2 Germany: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.2.3.1.2 Germany: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.2.3.2 United Kingdom: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2.3.2.1 United Kingdom: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.2.3.2.1.1 United Kingdom: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.2.3.2.1.2 United Kingdom: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.2.3.2.2 United Kingdom: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.2.3.3 France: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2.3.3.1 France: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.2.3.3.1.1 France: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.2.3.3.1.2 France: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.2.3.3.2 France: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.2.3.4 Italy: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2.3.4.1 Italy: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.2.3.4.1.1 Italy: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.2.3.4.1.2 Italy: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.2.3.4.2 Italy: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.2.3.5 Spain: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2.3.5.1 Spain: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.2.3.5.1.1 Spain: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.2.3.5.1.2 Spain: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.2.3.5.2 Spain: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.2.3.6 Rest of Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2.3.6.1 Rest of Europe: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.2.3.6.1.1 Rest of Europe: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.2.3.6.1.2 Rest of Europe: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.2.3.6.2 Rest of Europe: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.3 Asia Pacific
9.3.1 Asia Pacific Peripheral Liquid Embolic Agents Market Overview
9.3.2 Asia Pacific: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.3.2.1 Asia Pacific: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Type
9.3.2.2 Asia Pacific: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Type
9.3.2.2.1 Asia Pacific: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Polymerizing Liquid Embolic Agent
9.3.2.2.2 Asia Pacific: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Polymerizing Liquid Embolic Agent
9.3.2.2.3 Asia Pacific: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Precipitating Liquid Embolic Agent
9.3.2.2.4 Asia Pacific: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Precipitating Liquid Embolic Agent
9.3.2.3 Asia Pacific: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Application
9.3.3 Asia Pacific: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Country
9.3.3.1 China: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.3.3.1.1 China: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.3.3.1.1.1 China: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.3.3.1.1.2 China: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.3.3.1.2 China: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.3.3.2 Japan: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.3.3.2.1 Japan: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.3.3.2.1.1 Japan: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.3.3.2.1.2 Japan: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.3.3.2.2 Japan: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.3.3.3 India: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.3.3.3.1 India: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.3.3.3.1.1 India: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.3.3.3.1.2 India: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.3.3.3.2 India: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.3.3.4 Australia: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.3.3.4.1 Australia: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.3.3.4.1.1 Australia: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.3.3.4.1.2 Australia: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.3.3.4.2 Australia: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.3.3.5 South Korea: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.3.3.5.1 South Korea: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.3.3.5.1.1 South Korea: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.3.3.5.1.2 South Korea: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.3.3.5.2 South Korea: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.3.3.6 Rest of APAC: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.3.3.6.1 Rest of APAC: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.3.3.6.1.1 Rest of APAC: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.3.3.6.1.2 Rest of APAC: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.3.3.6.2 Rest of APAC: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.4 Middle East & Africa
9.4.1 Middle East & Africa Peripheral Liquid Embolic Agents Market Overview
9.4.2 Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.4.2.1 Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Type
9.4.2.2 Middle East & Africa: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Type
9.4.2.2.1 Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Polymerizing Liquid Embolic Agent
9.4.2.2.2 Middle East & Africa: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Polymerizing Liquid Embolic Agent
9.4.2.2.3 Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Precipitating Liquid Embolic Agent
9.4.2.2.4 Middle East & Africa: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Precipitating Liquid Embolic Agent
9.4.2.3 Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Application
9.4.3 Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Country
9.4.3.1 Saudi Arabia: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.4.3.1.1 Saudi Arabia: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.4.3.1.1.1 Saudi Arabia: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.4.3.1.1.2 Saudi Arabia: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.4.3.1.2 Saudi Arabia: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.4.3.2 South Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.4.3.2.1 South Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.4.3.2.1.1 South Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.4.3.2.1.2 South Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.4.3.2.2 South Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.4.3.3 United Arab Emirates: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.4.3.3.1 United Arab Emirates: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.4.3.3.1.1 United Arab Emirates: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.4.3.3.1.2 United Arab Emirates: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.4.3.3.2 United Arab Emirates: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.4.3.4 Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.4.3.4.1 Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.4.3.4.1.1 Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.4.3.4.1.2 Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.4.3.4.2 Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.5 South and Central America
9.5.1 South and Central America Peripheral Liquid Embolic Agents Market Overview
9.5.2 South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.5.2.1 South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Type
9.5.2.2 South and Central America: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Type
9.5.2.2.1 South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Polymerizing Liquid Embolic Agent
9.5.2.2.2 South and Central America: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Polymerizing Liquid Embolic Agent
9.5.2.2.3 South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Precipitating Liquid Embolic Agent
9.5.2.2.4 South and Central America: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Precipitating Liquid Embolic Agent
9.5.2.3 South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Application
9.5.3 South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Country
9.5.3.1 Brazil: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.5.3.1.1 Brazil: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.5.3.1.1.1 Brazil: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.5.3.1.1.2 Brazil: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.5.3.1.2 Brazil: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.5.3.2 Argentina: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.5.3.2.1 Argentina: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.5.3.2.1.1 Argentina: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.5.3.2.1.2 Argentina: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.5.3.2.2 Argentina: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.5.3.3 Rest of South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.5.3.3.1 Rest of South and Central America: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.5.3.3.1.1 Rest of South and Central America: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.5.3.3.1.2 Rest of South and Central America: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.5.3.3.2 Rest of South and Central America: Peripheral Liquid Embolic Agents Market Breakdown, by Application
10. Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Peripheral Liquid Embolic Agents Market
10.3 Inorganic Growth Strategies
10.3.1 Overview
10.4 Organic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Medtronic Plc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 B Braun SE
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Guerbet SA
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Sirtex Medical Ltd
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Balt
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 MicroVention Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Johnson & Johnson
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 GEM srl
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
List of Tables
Table 1. Peripheral Liquid Embolic Agents Market Segmentation
Table 2. Regional Pricing Analysis, Price (US$)/ML, 2023
Table 3. Liquid Embolic Agents Under Trial for Temperature-Sensitive and pH-Triggered Gelation
Table 4. Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 5. Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 6. North America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 7. North America: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Type
Table 8. North America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 9. North America: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Polymerizing Liquid Embolic Agent
Table 10. North America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 11. North America: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Precipitating Liquid Embolic Agent
Table 12. North America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 13. Canada: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 14. Canada: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 15. Canada: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 16. Canada: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 17. Mexico: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 18. Mexico: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 19. Mexico: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 20. Mexico: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 21. Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 22. Europe: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Type
Table 23. Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 24. Europe: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Polymerizing Liquid Embolic Agent
Table 25. Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 26. Europe: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Precipitating Liquid Embolic Agent
Table 27. Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 28. Germany: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 29. Germany: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 30. Germany: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 31. Germany: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 32. United Kingdom: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 33. United Kingdom: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 34. United Kingdom: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 35. United Kingdom: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 36. France: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 37. France: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 38. France: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 39. France: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 40. Italy: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 41. Italy: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 42. Italy: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 43. Italy: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 44. Spain: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 45. Spain: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 46. Spain: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 47. Spain: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 48. Rest of Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 49. Rest of Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 50. Rest of Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 51. Rest of Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 52. Asia Pacific: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 53. Asia Pacific: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Type
Table 54. Asia Pacific: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 55. Asia Pacific: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Polymerizing Liquid Embolic Agent
Table 56. Asia Pacific: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 57. Asia Pacific: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Precipitating Liquid Embolic Agent
Table 58. Asia Pacific: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 59. China: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 60. China: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 61. China: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 62. China: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 63. Japan: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 64. Japan: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 65. Japan: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 66. Japan: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 67. India: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 68. India: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 69. India: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 70. India: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 71. Australia: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 72. Australia: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 73. Australia: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 74. Australia: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 75. South Korea: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 76. South Korea: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 77. South Korea: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 78. South Korea: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 79. Rest of APAC: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 80. Rest of APAC: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 81. Rest of APAC: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 82. Rest of APAC: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 83. Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 84. Middle East & Africa: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Type
Table 85. Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 86. Middle East & Africa: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Polymerizing Liquid Embolic Agent
Table 87. Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 88. Middle East & Africa: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Precipitating Liquid Embolic Agent
Table 89. Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 90. Saudi Arabia: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 91. Saudi Arabia: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 92. Saudi Arabia: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 93. Saudi Arabia: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 94. South Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 95. South Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 96. South Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 97. South Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 98. United Arab Emirates: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 99. United Arab Emirates: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 100. United Arab Emirates: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 101. United Arab Emirates: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 102. Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 103. Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 104. Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 105. Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 106. South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 107. South and Central America: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Type
Table 108. South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 109. South and Central America: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Polymerizing Liquid Embolic Agent
Table 110. South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 111. South and Central America: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Precipitating Liquid Embolic Agent
Table 112. South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 113. Brazil: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 114. Brazil: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 115. Brazil: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 116. Brazil: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 117. Argentina: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 118. Argentina: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 119. Argentina: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 120. Argentina: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 121. Rest of South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 122. Rest of South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 123. Rest of South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 124. Rest of South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 125. Recent Inorganic Growth Strategies in the Peripheral Liquid Embolic Agents Market
Table 126. Recent Organic Growth Strategies in the Peripheral Liquid Embolic Agents Market
Table 127. Glossary of Terms, Peripheral Liquid Embolic Agents Market
List of Figures
Figure 1. Peripheral Liquid Embolic Agents Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Peripheral Liquid Embolic Agents Market Revenue (US$ Thousand), 2021–2031
Figure 5. Manufacturers Market Positioning, 2023
Figure 6. Peripheral Liquid Embolic Agents Market Share (%) – by Type (2023 and 2031)
Figure 7. Polymerizing Liquid Embolic Agent: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 8. Precipitating Liquid Embolic Agent: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 9. Peripheral Liquid Embolic Agents Market Share (%) – by Application (2023 and 2031)
Figure 10. Endoleak Type II: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 11. Malformations: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 12. Bleedings and Trauma: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 13. Varicose Vein: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 14. Tumours: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 15. Visceral Aneurysm: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 16. North America Peripheral Liquid Embolic Agents Market by Key Countries, 2023
Figure 17. North America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 18. North America: Peripheral Liquid Embolic Agents Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 19. Canada: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 20. Mexico: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 21. Europe Peripheral Liquid Embolic Agents Market by Key Countries, 2023
Figure 22. Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 23. Europe: Peripheral Liquid Embolic Agents Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 24. Germany: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 25. United Kingdom: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 26. France: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 27. Italy: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 28. Spain: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 29. Rest of Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 30. Asia Pacific Peripheral Liquid Embolic Agents Market by Key Countries, 2023
Figure 31. Asia Pacific: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 32. Asia Pacific: Peripheral Liquid Embolic Agents Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 33. China: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 34. Japan: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 35. India: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 36. Australia: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 37. South Korea: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 38. Rest of APAC: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 39. Middle East & Africa Peripheral Liquid Embolic Agents Market by Key Countries, 2023
Figure 40. Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 41. Middle East & Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 42. Saudi Arabia: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 43. South Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 44. United Arab Emirates: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 45. Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 46. South & Central America Peripheral Liquid Embolic Agents Market by Key Countries, 2023
Figure 47. South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 48. South and Central America: Peripheral Liquid Embolic Agents Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 49. Brazil: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 50. Argentina: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 51. Rest of South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 52. Growth Strategies in the Peripheral Liquid Embolic Agents Market
The List of Companies - Peripheral Liquid Embolic Agents Market
- Medtronic
- B Braun SE
- Guerbet SA
- Sirtex Medical Ltd
- Balt
- MicroVention Inc
- Johnson & Johnson
- GEM srl
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For